Yahoo
    NasdaqCM - Delayed Quote USD

    Pulmatrix, Inc. (PULM)

    1.4000 -0.0200 (-1.41%)
    At close: October 30 at 4:00:00 PM EDT
    Loading Chart for PULM
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    Eos SENOLYTIX Reports Interim Data Showing Preserved Physical Function with MitoXcel Geropeptide PTC-2105 in a Second Species, Aged-Rat Study

    Eos SENOLYTIX Reports Interim Data Showing Preserved Physical Function with MitoXcel Geropeptide PTC-2105 in a Second Species, Aged-Rat Study
    GlobeNewswire 2d ago
    Pulmatrix Announces First Quarter 2026 Financial Results

    Pulmatrix Announces First Quarter 2026 Financial Results
    PR Newswire 5mo ago
    Pulmatrix Announces Closing of Preferred Stock Transaction as Part of Planned Merger

    Pulmatrix Announces Closing of Preferred Stock Transaction as Part of Planned Merger
    PR Newswire 6mo ago
    Eos SENOLYTIX Presents Late-Life Survival and Healthspan Data for Mitochondria-Targeted Geropeptide PTC-2105 at the 17th World Congress on Targeting Mitochondria, and Launches “Team Speedy” to Let the Public Follow Its Longest-Lived Mouse

    Eos SENOLYTIX Presents Late-Life Survival and Healthspan Data for Mitochondria-Targeted Geropeptide PTC-2105 at the 17th World Congress on Targeting Mitochondria, and Launches “Team Speedy” to Let the Public Follow Its Longest-Lived Mouse
    GlobeNewswire 10d ago
    Eos SENOLYTIX to Highlight Next-Generation Mitochondria-Targeted Therapeutics at 17th World Congress on Targeting Mitochondria

    Eos SENOLYTIX to Highlight Next-Generation Mitochondria-Targeted Therapeutics at 17th World Congress on Targeting Mitochondria
    GlobeNewswire 1mo ago
    Wave crashes on obesity drug update; Kodiak’s reboot pays dividends

    Wave crashes on obesity drug update; Kodiak’s reboot pays dividends
    BioPharma Dive 7mo ago
    Pulmatrix Announces Second Quarter 2026 Financial Results and Progress on Merger

    Pulmatrix Announces Second Quarter 2026 Financial Results and Progress on Merger
    PR Newswire 2mo ago
    Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan

    Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan
    PR Newswire 7mo ago
    Pulmatrix Announces Termination of Prior Planned Merger and Continues Pursuit of Alternative Merger Opportunities

    Pulmatrix Announces Termination of Prior Planned Merger and Continues Pursuit of Alternative Merger Opportunities
    PR Newswire 7mo ago
    Pulmatrix and Cullgen Continue to Pursue Merger While Granting Each Other Waivers to Explore Alternatives

    Pulmatrix and Cullgen Continue to Pursue Merger While Granting Each Other Waivers to Explore Alternatives
    PR Newswire 10mo ago

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: